* BMSYSTEMS (BIO-MODELING) *
2004 - IDF
Paris
www.bmsystems.net Discovery, Hub
Key words: Models, Proof of concept, Predictive efficacy, Validation, Spin-off
Mission: to help clients run their life sciences R&D programs better, faster, cheaper and safer by applying CADI methodologies and tools, an operational systems biology approach
Clients: R&D departments (on a partnering basis), Financers (in case of spin-off)
bioweb@bmsystems.net
Age: 5 year(s)
Identity| TYPE/MANAGEMENT/INVESTORS | FINANCES/STATUS | | Start-up |
Managing Dir.-CEO: Géa (Manuel) [co-founder, born 1960, Eng. Centrale, ex-Hemispherx (CEO), Boehringer-Ingelheim, Colgate-Palmolive, McKinsey]
Sc.Dir.-CSO: Iris (François) [also board chairman, born 1950, Ph.D., ex-Valigen (co-founder), Millenium]
Med.Dir.-CMO: Dine (Gérard) [M.D., Ph.D.]
I.T.Dir.-CIO: Santamaria (Pablo) [Eng. Centrale, ex-Formitel, Glaxo]
Fin.Dir.-CFO:
BusDev:
Financers (Hist.): privately-owned (no search for external investors) | Turnover (M€) : n.a.
Total funding (M€) : n.a.
Last funding (M€) : n.a.
Focus : Multiple
Position : Proof-of-Concept
Company confirm : none |
History | DATE | MILESTONE | TYPE | TIME | | 2009 .06 | Launch of BioXplain, the first open platform for Iterative, Predictive and Integrative Biology, with BioXpr (Belgium) and Kayentis (electronic pen) | MKTG | [4 years] |
| 2008 .09 | Patent : application, with CEA life Sciences, covering new therapeutic strategies and a preclinical evaluation platform for psychiatric disorders | LEGAL | [4 years] |
| 2006 .12 | Spin-off of Pherecydes (keeping minority equity) | ACQ- | [2 years] |
| 2004 .08 | Company founded by Manuel Géa, François Iris, Gérard Dine, Paul-Henri Lampe, Pablo Santamaria | ORGF | [0 year] | Actualisation / Updating: 21-Sept-2009 |
|
